CervoMed Announces Addition To Russell 2000 And Russell 3000 Indexes
CervoMed Announces Addition To Russell 2000 And Russell 3000 Indexes
CervoMed宣布加入Russell 2000和Russell 3000指数
CervoMed Inc. (NASDAQ:CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced its expected addition to the Russell 2000 and Russell 3000 Indexes at the conclusion of the 2024 Russell U.S. Indexes annual reconstitution, effective when the U.S. equity markets open on Monday, July 1, 2024, according to the final preliminary list of 2024 additions posted on the FTSE Russell website on June 21st 2024.
CervoMed Inc.（纳斯达克股票代码：CRVO），一家专注于开发治疗老年神经性疾病的临床阶段公司，今天宣布预计将在2024年Russell美国指数年度重新编制的最终初步名单中被纳入Russell 2000和Russell 3000指数，有效期至2024年7月1日星期一美国股票市场开盘，在FTSE Russell网站于2024年6月21日发布的2024年新增榜单中。